Medicinal cannabis for chronic pain: The bermuda triangle of low‐quality studies, countless meta‐analyses and conflicting recommendations-Reference-Cited by-同舟云学术

Medicinal cannabis for chronic pain: The bermuda triangle of low‐quality studies, countless meta‐analyses and conflicting recommendations

Published:2022-04-06 Issue:6 Volume:26 Page:1183-1185
ISSN:1090-3801
Container-title:European Journal of Pain
language:en
Short-container-title:European Journal of Pain

Author:

Eisenberg Elon¹,Morlion Bart²,Brill Silviu³,Häuser Winfried⁴⁵

Affiliation:

1. Institute of Pain Medicine Rambam Health Care Campus, and Technion – Israel Institute of Technology Haifa Israel

2. Leuven Center for Algology & Pain Management University Hospitals Leuven Leuven KU Belgium

3. Institute for Pain Medicine Sourasky Medical Center Tel Aviv Israel

4. Internal Medicine 1 Klinikum Saarbrücken gGmbH Saarbrücken Germany

5. Department Psychosomatic Medicine and Psychotherapy Technische Universität München Munich Germany

Publisher

Wiley

Subject

Anesthesiology and Pain Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejp.1946

Reference5 articles.

1. Medical cannabis treatment for chronic pain: Outcomes and prediction of response

2. Cannabinoids, cannabis, and cannabis-based medicine for pain management

3. European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management

4. International Association for the Study of Pain. (2021).IASP Position Statement on the Use of Cannabinoids to Treat Pain. March 21 2021. Retrieved fromhttps://www.iasp‐pain.org/publications/iasp‐news/iasp‐position‐statement‐on‐the‐use‐of‐cannabinoids‐to‐treat‐pain/Accessed November 1 2021

5. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview: Chronic Pain and Cannabis-Based Medicines;Pharmacopsychiatry;2024-01-10

2. Drug interactions of tetrahydrocannabinol and cannabidiol in cannabinoid drugs;Deutsches Ärzteblatt international;2023-12-08

3. High-cost and high-dose prescriptions of cannabis-based medicines;Deutsches Ärzteblatt international;2023-11-24

4. Medical cannabis for refractory cancer-related pain in a specialised clinical service: a cross-sectional study;BMJ Supportive & Palliative Care;2023-11-16

5. Medical Cannabis Is Not Associated with a Decrease in Activities of Daily Living in Older Adults;Biomedicines;2023-10-03